Cryoport, Inc.
CYRX · Pharmaceutical Preparations
Latest available SEC filing: SCHEDULE 13G/A ·
Latest disclosures
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Shelton Jerrell: Form 4
Insider disclosure · Filed · Report period 11 Aug 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001124524 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CYRX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 112 Westwood Place, Suite 350, Brentwood, TN, 37027
- Incorporated in
- NV
- Fiscal year end
- 31 December
- Former names on EDGAR
- CRYOPORT SYSTEMS INC (to 20 Oct 2005)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields